硼替佐米
细胞凋亡
K562细胞
流式细胞术
化学
细胞生长
药理学
癌症研究
生物
分子生物学
免疫学
多发性骨髓瘤
生物化学
作者
Zhiqiang Jia,Yongzhong Wei,Ying Wei,Wei Su,Chunxia Yu,Tao Jin,Hong-Qi Rong
出处
期刊:PubMed
日期:2014-10-01
卷期号:22 (5): 1291-4
标识
DOI:10.7534/j.issn.1009-2137.2014.05.020
摘要
This study was aimed to investigate the effects of bortezomib combined with 5-azacytidine on the apoptosis of K562 cells and expressiom of SHIP mRNA. The K562 cells were cultured and treated with different concentrations of bortezomib, 5-azacytidine or their combination for 24 hours. Then, the expression of SHIP mRNA was detected by RT-PCR,the cell proliferation was analyzed by using MTT assay and flow cytometry. The results showed that 5-20 nmol/L bortezomib could effectively inhibit the proliferation of K562 and this inhibitory effect gradually enhanced along with the increase of bortezomib concentration, the group of bortezomib combined with 5-azacytidine showed more inhibitory effect on K562 cells than that of bortezomib or 5-azacytidine alone.The bortezomib could promote the apoptosis of K562 cells in a dose-dependent manner,and this apoptotic effect was higher in group of bortezomib combined with 5-azacytidine than that in group of bortezomib or 5-azacytidine alone.Bortezomib could down-regulated the expression of SHIP mRNA in a dose-dependent manner,and this down-requlated effect was higher in group of bortezomib combined with 5-azacytidine than that in group of bortezomib or 5-azacytidine alone.It is concluded that bortezomib and 5-azacytidine can induce apoptosis by inhibiting the expression of SHIP mRNA in K562 cells.The combination of bortezomib with 5-azacytidine displays a synergetic effect.
科研通智能强力驱动
Strongly Powered by AbleSci AI